(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hex-5-enoic acid, 95.0%, 5g

4-Amino-2,3-dichlorophenol, 95.0%, 10g

Butyl 2-Chloroethyl Ether>98.0%(GC)25mL

1,8-Naphthyridine-2-carboxylic acid hydrobromide, 95.0%, 2.5g

4-Nitro-1H-pyrazole, 97.0%, 5g

GC capillary column ROTI®Cap-1701 MS, 60 m, 0.32 mm, 0.50 µm, 1 Piece(s)

Diethyl malonimidate dihydrochloride, 95.0%, 10g

5-(Benzylamino)pentan-1-ol, 98%, 1g

(Z)-Hex-3-en-1-ol, 95.0%, 100g

4,5,6,7-Tetrahydro-2,1-benzisoxazole-3-carboxylic acid, 95.0%, 250mg

3-CHLORO-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID, 95.0%, 10g

2,2,2-Trifluoro-1-(1H-indol-5-yl)ethanone, 250mg

1-(3,5-Bis(trifluoromethyl)phenyl)-3-((1S,2S)-2-(dimethylamino)cyclohexyl)thiourea, 98.0%, 5g